PubMed
Delta sleep-inducing peptide (DSIP): A review
Graf MV, Kastin AJ. Neurosci Biobehav Rev. 1986
Compare
Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.
Last reviewed . By the PeptIQ team.
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 54% · Mixed 32% · Unfavorable overall 14%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 0.6–1 mg · Most common: 0.4–0.6 mg
Reports span 0.05–5 mg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 64% said they felt similar to their last entry, 34% more positive, and 14% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 32 days · Based on 403 repeat reporters
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 47% · Mixed 40% · Unfavorable overall 13%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 0.2–0.4 mg · Most common: 0.2–0.4 mg
Reports span 0.01–2 mg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 57% said they felt similar to their last entry, 45% more positive, and 17% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 19 days · Based on 355 repeat reporters
Published sources linked on the DSIP and VIP wiki pages.
PubMed
Graf MV, Kastin AJ. Neurosci Biobehav Rev. 1986
PubMed
Sudakov KV, Koplik EV, Umriukhin PE. Peptides. 1988
ClinicalTrials.gov
ClinicalTrials.gov. Clinical trial registry. 2024
PubMed
Pollard BJ, Pomfrett CJ. European journal of anaesthesiology. 2001
PubMed
Graf MV, Kastin AJ. Neuroscience and biobehavioral reviews. 1984
PubMed
Ghatei MA, Takahashi K, Suzuki H, et al. J Cardiovasc Pharmacol. 2003
PubMed
Delgado M, Chorny A, Gonzalez-Rey E, et al. J Leukoc Biol. 2005
PubMed
Delgado M, Ganea D. Amino Acids. 2013
PubMed
Henning RJ, Sawmiller DR. Cardiovascular Research. 2001
PubMed
Vosko AM, Schroeder A, Loh DH, et al. General and Comparative Endocrinology. 2007
PubMed
Kingsbury MA. Current Opinion in Behavioral Sciences. 2015
ClinicalTrials.gov
ClinicalTrials.gov. Clinical trial registry. 2024
PubMed
Delgado M, Pozo D, Ganea D. Pharmacological reviews. 2004
PubMed
Jiang W, Wang H, Li YS, et al. Journal of biomedical science. 2016